S'abonner navigation icon
FR
navigation icon menu icon S'abonner
navigation icon Accueil navigation icon Catalogue
icon language Langues navigation icon Menu
icon close
icon arrow

Rechercher

icon searchbar

Rechercher

Catalogue

icon close
icon close
icon close
icon language

Langues

icon close
background image
button download
icon share social
Category Preclinical Data Support the Potential of AmVacs RSV Vaccine
Lire
Lire

Preclinical Data Support the Potential of AmVacs RSV Vaccine

  • 1

    page

  • English

  • Documents

Publié par
icon arrow

  • 1

    page

  • English

  • Documents

Lire
Lire
icon

Description

Preclinical Data Support the Potential of AmVacs RSV Vaccine PR Newswire ZUG, Switzerland, October 29, 2012 ZUG, Switzerland, October 29, 2012 /PRNewswire/ -- Innovative approach to the prevention of severe respiratory infections AmVac AG has announced that it has made decisive progress in the development of their new RSV vaccine.
Voir icon arrow
icon success

Ajouté à mes notifications

Vous serez informé des prochaines publications.